Andrew P. Smith

2016

In 2016, Andrew P. Smith earned a total compensation of $1.1M as Former Chief Financial Officer at Sucampo Pharmaceuticals, a 25% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$183,961
Option Awards$415,502
Salary$364,518
Other$95,894
Total$1,059,874

Smith received $415.5K in option awards, accounting for 39% of the total pay in 2016.

Smith also received $184K in non-equity incentive plan, $364.5K in salary and $95.9K in other compensation.

Rankings

In 2016, Andrew P. Smith's compensation ranked 7,963rd out of 14,075 executives tracked by ExecPay. In other words, Smith earned more than 43.4% of executives.

ClassificationRankingPercentile
All
7,963
out of 14,075
43rd
Division
Manufacturing
3,036
out of 5,489
45th
Major group
Chemicals And Allied Products
1,008
out of 1,895
47th
Industry group
Drugs
780
out of 1,538
49th
Industry
Pharmaceutical Preparations
618
out of 1,176
47th
Source: SEC filing on April 21, 2017.

Smith's colleagues

We found four more compensation records of executives who worked with Andrew P. Smith at Sucampo Pharmaceuticals in 2016.

2016

Peter Greenleaf

Sucampo Pharmaceuticals

Chief Executive Officer

2016

Peter Kiener

Sucampo Pharmaceuticals

Chief Scientific Officer

2016

Max Donley

Sucampo Pharmaceuticals

EVP, Global Human Resources, Information Technology and Strategy

2016

Matthias Alder

Sucampo Pharmaceuticals

General Counsel

You may also like